Form 4 for ELAN Elanco Animal Health Inc
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0001415889-25-005168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-19 | ELAN | Kinard David S | SEE REMARKS | A - Grant | $0.00 | +40.2K | 191.9K | +27% | $0 | |
| 2025-02-21 | 2025-02-19 | ELAN | Kinard David S | SEE REMARKS | F - Tax | $11.24 | -18.0K | 173.9K | -9% | -$202.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | A | A | 40,247 | $0.00 | 191,903 | D | — | — | (F1) Includes 454 shares acquired on April 30, 2024, 524 shares acquired on July 31, 2024, 464 shares acquired on October 31, 2024, and 568 shares acquired on January 31, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-02-19 | F | D | 17,968 | $11.24 | 173,935 | D | — | — |